Molecular Oncology is a monthly online-only Open Access journal that highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research. It is a not-for-profit journal owned by the Federation of European Biochemical Societies (FEBS).
Molecular Oncology’s emphasis is on work that significantly advances our understanding of disease processes leading to human tumour development and/or establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies for cancer patients.
Molecular Oncology is an affiliated journal of the European Association for Cancer Research and we work together on a number of activities, including:
The EACR is grateful for the continued support of its Industry Partners: